Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : sciclone pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: JEB who wrote (829)	8/3/2001 10:21:44 PM
From: Captain Jack	Read Replies (1) \| Respond to of 1137

JEB-- you hit the nail on the head-- SALES! Excuses do not cut it and they were not that good anyway. Sadly, they have a lot to offer to the medical field & SHs. Research and testing seems to go in the right direction it is the stock that sux. Without sales it will continue to do so. Any US approval should give it a great pop. As long as the SP cannot sustain $5+++ there will be no institutional interest. It really needs to get to 7 and hold the range for institutions to return.